Cargando…

Stem cell-based therapy for inflammatory bowel disease

Inflammatory bowel disease (IBD) is an idiopathic, multi-etiological disease characterized by inflammation and mucosal destruction of the gastrointestinal tract. Despite the remarkable advance in immunomodulating therapies, there still remains a certain population of patients who are refractory to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Hiromichi, Suzuki, Kohei, Watanabe, Mamoru, Okamoto, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667367/ https://www.ncbi.nlm.nih.gov/pubmed/31352774 http://dx.doi.org/10.5217/ir.2019.00043

Ejemplares similares

Organoid-based regenerative medicine for inflammatory bowel disease
por: Okamoto, Ryuichi, et al.
Publicado: (2020)

Artificial intelligence for endoscopy in inflammatory bowel disease
por: Takenaka, Kento, et al.
Publicado: (2022)

Stem Cell-Based Therapies for Inflammatory Bowel Disease
por: Zhang, Hua-Min, et al.
Publicado: (2022)

Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
por: Mishra, Rangnath, et al.
Publicado: (2020)

Stem Cell Therapy for Inflammatory Bowel Disease
por: Lightner, Amy L
Publicado: (2017)

Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease
por: Yasutomi, Yusuke, et al.
Publicado: (2021)

Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
por: Shi, Meng-Yue, et al.
Publicado: (2022)

Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges
por: Tian, Cheng-Mei, et al.
Publicado: (2023)

Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy
por: Saadh, Mohamed J., et al.
Publicado: (2023)

Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
por: Tsuchiya, Atsunori, et al.
Publicado: (2017)

Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2021)

Single cell analysis of Crohn’s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties
por: Suzuki, Kohei, et al.
Publicado: (2018)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy
por: Turse, Erica P, et al.
Publicado: (2018)

Diet–Microbiota Interactions in Inflammatory Bowel Disease
por: Sugihara, Kohei, et al.
Publicado: (2021)

Stem cell therapeutics: potential in the treatment of inflammatory bowel disease
por: Swenson, ES, et al.
Publicado: (2010)

Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
por: Mao, Fei, et al.
Publicado: (2017)

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
por: Nakase, Hiroshi, et al.
Publicado: (2021)

The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Iron Therapy in Inflammatory Bowel Disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Antioxidant Therapy in Inflammatory Bowel Diseases
por: Dziąbowska-Grabias, Katarzyna, et al.
Publicado: (2021)

Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease
por: Iida, Tomoya, et al.
Publicado: (2018)

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus
por: Shimizu, Hiromichi, et al.
Publicado: (2021)

Evidence-based clinical practice guidelines for inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

RNA interference-based nanosystems for inflammatory bowel disease therapy
por: Guo, Jian, et al.
Publicado: (2016)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease
por: Dailey, Francis E, et al.
Publicado: (2018)

Endoscopic Therapy in Inflammatory Bowel Diseases
por: Neumann, Helmut, et al.
Publicado: (2015)

PGE(2) is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells
por: Fujii, Satoru, et al.
Publicado: (2016)

Diet supporting therapy for inflammatory bowel diseases
por: Kikut, Justyna, et al.
Publicado: (2021)

Electrical neuromodulation therapy for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review
por: Ko, Jeffrey Zheng-Hsien, et al.
Publicado: (2021)

The Etiology of Pancreatic Manifestations in Patients with Inflammatory Bowel Disease
por: Iida, Tomoya, et al.
Publicado: (2019)

Contribution of ATOH1(+) Cells to the Homeostasis, Repair, and Tumorigenesis of the Colonic Epithelium
por: Ishibashi, Fumiaki, et al.
Publicado: (2017)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
por: Che, Zhengping, et al.
Publicado: (2022)

Small Bowel Endoscopy in Inflammatory Bowel Disease
por: Yamagami, Hirokazu, et al.
Publicado: (2013)

Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan
por: Sagami, Shintaro, et al.
Publicado: (2021)

Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7h71ds72bml0m7b71aest5noe4